Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Lunch and Poster Display session

89P - BIMAP: Breast cancer intra-operative margin assessment using PET-CT

Date

16 May 2024

Session

Lunch and Poster Display session

Presenters

Anne-Sofie De Crem

Citation

Annals of Oncology (2024) 9 (suppl_4): 1-9. 10.1016/esmoop/esmoop103095

Authors

A. De Crem1, P. Tummers1, H. Depypere1, G. Braems1, R. Salihi1, G. Vergauwen1, G. Cisternino2, K. Van De Vijver3, P. De Visschere1, K. De Man3, B. Van den Broeck3, L. Veldeman3, C. Monten3, H. Denys1, M. Göker3

Author affiliations

  • 1 UZ Gent - University Hospital Ghent, Gent/BE
  • 2 IRCCS San Raffaele Scientific Institute, Milan/IT
  • 3 UZ Gent - Universitair Ziekenhuis Gent, Gent/BE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 89P

Background

Positive surgical margins for breast cancer (BC), defined as ink on tumor, occur in 20% of cases. Therefore, finding a time- and cost-effective method for intra-operative margin assessment is crucial to avoid the need for re-operation. Our study aimed to evaluate the feasibility and effectiveness of an intra-operative micro-Positron Emission Tomography - Computed Tomography (PET-CT) specimen imager for assessing margins in BC patients undergoing breast-conserving surgery.

Methods

Forty-one patients with early-stage BC were enrolled in this pilot study at Ghent University Hospital from June 2017 until June 2022. Intra-operative imaging of the specimens was performed by the ß-CUBE (micro-PET) and X-CUBE (micro-CT), later joined as one intra-operative micro-PET-CT called AURA 10 (XEOS, Ghent, Belgium). All images were interpreted at an acquisition time of 10 minutes and a 18F-FDG dose of 0.8 MBq/kg. Seven doctors, including four gynaecologists, two nuclearists and one radiologist, assessed margin status post-operative as positive, close (<1mm) or negative (no intra-operative intervention). Sensitivity and specificity were calculated by using histopathology as the golden standard.

Results

Invasive ductal carcinoma (IDC) ± ductal carcinoma in situ (DCIS) was seen in 31 patients, other types were lobular carcinoma (n=6), DCIS only (n=2) and neo-adjuvant therapy (n=2). Margin assessment of IDC ± DCIS, resulted in a mean sensitivity of 91%, specificity of 94% and accuracy of 87% (close margins were seen as positive). Positive margins of IDC on histopathology were observed in 29% (9/31) of cases. Micro-PET-CT correctly identified 8 out of 9 positive margins, and all doctors agreed on these findings (k=1). An immediate cavity shave was done in 45% (4/9) based on specimen radiography (standard of care) but 55% (5/9) still required re-operation. Notably, 16% (5/31) needed a re-operation for a positive margin that was already identified by all doctors on micro-PET-CT.

Conclusions

Our results with the micro-PET-CT specimen imager demonstrated high sensitivity and specificity for assessing tumour margins in IDC (± DCIS). This device has the potential to reduce re-operation rates more efficiently by allowing immediate and precise cavity shaves during initial surgery (NNT = 4).

Legal entity responsible for the study

Ghent University Hospital.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.